First Tracks Biotherapeutics, Inc.
TRAX
$15.97
$0.221.40%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 286.46M | 385.37M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 2.95M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 289.40M | -- | |||
|
|
|||||
| Total Current Assets | 289.40M | -- | |||
| Net Property, Plant & Equipment | 1.17M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 290.58M | -- | |||
|
|
|||||
| Total Accounts Payable | 7.50M | -- | |||
| Total Accrued Expenses | 25.62M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | 33.11M | -- | |||
|
|
|||||
| Total Current Liabilities | 33.11M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 33.11M | -- | |||
|
|
|||||
| Common Stock & APIC | 257.61M | -- | |||
| Retained Earnings | -- | -- | |||
| Treasury Stock & Other | -146.00K | -- | |||
| Total Common Equity | 257.46M | 391.60M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 257.46M | 391.60M | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 257.46M | 391.60M | |||
|
|
|||||